Literature DB >> 1627807

Detection of circulating donor white blood cells in patients receiving multiple transfusions.

P T Adams1, R D Davenport, D A Reardon, M S Roth.   

Abstract

Significant morbidities are associated with the routine administration of blood products. Although the exact etiology of these complications may be unknown, many are thought to arise from the incidental cotransfusion of "donor" lymphocytes. We have developed an assay to detect small numbers of male white blood cells (WBCs) circulating in female patients who have received multiple blood transfusions using the polymerase chain reaction (PCR). Twenty female patients undergoing major surgical procedures were studied and received an average of 9.3 U of packed red blood cells (4.8 U from male donors) and 11.7 U of platelets (6.1 U from male donors). DNA was extracted from whole blood or peripheral blood buffy coats posttransfusion and PCR performed using oligonucleotides designed to amplify a segment within the repetitive Y-chromosome DYZ1 locus. Posttransfusion, 15 of 20 women showed evidence of circulating male WBCs for an average of 2.0 days (range, 1 to 6). We conclude that (1) DYZ1 PCR analysis is a useful approach for the detection of small numbers of circulating transfused male WBCs in female patients; and (2) circulating donor WBCs persist for a mean of 2.0 days in the majority of women receiving multiple transfusions. Future application of this technique may detect persisting or proliferating WBCs and lead to an improved understanding of common transfusion-related morbidities.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627807

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Blood group genotyping facilitates transfusion of beta-thalassemia patients.

Authors:  Lilian Castilho; Maria Rios; Jordão Pellegrino; Sara T O Saad; Fernando F Costa
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

2.  Benefits of blood group genotyping in multi-transfused patients from the south of Brazil.

Authors:  Gláucia Andréia Soares Guelsin; Ana Maria Sell; Lilian Castilho; Viviane Lika Masaki; Fabiano Cavalcante Melo; Margareth Naomi Hashimoto; Tatiana Takahashi Higa; Loide Souza Hirle; Jeane Eliete Laguila Visentainer
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Can post-mortem blood be used for DNA profiling after peri-mortem blood transfusion?

Authors:  E A M Graham; M Tsokos; G N Rutty
Journal:  Int J Legal Med       Date:  2005-12-10       Impact factor: 2.686

Review 4.  Transfusion-associated microchimerism: the hybrid within.

Authors:  Evan M Bloch; Rachael P Jackman; Tzong-Hae Lee; Michael P Busch
Journal:  Transfus Med Rev       Date:  2012-10-24

Review 5.  Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

Authors:  Pawel Muranski; Andrea Boni; Claudia Wrzesinski; Deborah E Citrin; Steven A Rosenberg; Richard Childs; Nicholas P Restifo
Journal:  Nat Clin Pract Oncol       Date:  2006-12

6.  Genotyping patients with recent blood transfusions.

Authors:  Michelle Ng Gong; Yang Sai; Wei Zhou; B Taylor Thompson; Li-Lian Xu; David C Christiani
Journal:  Epidemiology       Date:  2003-11       Impact factor: 4.822

7.  Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.

Authors:  Andrea Boni; Pawel Muranski; Lydie Cassard; Claudia Wrzesinski; Chrystal M Paulos; Douglas C Palmer; Luca Gattinoni; Christian S Hinrichs; Chi-Chao Chan; Steven A Rosenberg; Nicholas P Restifo
Journal:  Blood       Date:  2008-09-17       Impact factor: 22.113

8.  Safety and Efficacy of Transplantation with Allogeneic Skin Tumors to Treat Chemically-Induced Skin Tumors in Mice.

Authors:  Zhiwei Zhang; Hua Sun; Jianhua Zhang; Chunlei Ge; Suwei Dong; Zhen Li; Ruilei Li; Xiaodan Chen; Mei Li; Yun Chen; Yingying Zou; Zhongyi Qian; Lei Yang; Jinyan Yang; Zhitao Zhu; Zhimin Liu; Xin Song
Journal:  Med Sci Monit       Date:  2016-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.